Literature DB >> 22057887

Innate and adaptive immune responses against Staphylococcus aureus skin infections.

Sheila Krishna1, Lloyd S Miller.   

Abstract

Staphylococcus aureus is an important human pathogen that is responsible for the vast majority of bacterial skin and soft tissue infections in humans. S. aureus can also become more invasive and cause life-threatening infections such as bacteremia, pneumonia, abscesses of various organs, meningitis, osteomyelitis, endocarditis, and sepsis. These infections represent a major public health threat due to the enormous numbers of these infections and the widespread emergence of methicillin-resistant S. aureus (MRSA) strains. MSRA is endemic in hospitals worldwide and is rapidly spreading throughout the normal human population in the community. The increasing frequency of MRSA infections has complicated treatment as these strains are more virulent and are increasingly becoming resistant to multiple different classes of antibiotics. The important role of the immune response against S. aureus infections cannot be overemphasized as humans with certain genetic and acquired immunodeficiency disorders are at an increased risk for infection. Understanding the cutaneous immune responses against S. aureus is essential as most of these infections occur or originate from a site of infection or colonization of the skin and mucosa. This review will summarize the innate immune responses against S. aureus skin infections, including antimicrobial peptides that have direct antimicrobial activity against S. aureus as well as pattern recognition receptors and proinflammatory cytokines that promote neutrophil abscess formation in the skin, which is required for bacterial clearance. Finally, we will discuss the recent discoveries involving IL-17-mediated responses, which provide a key link between cutaneous innate and adaptive immune responses against S. aureus skin infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057887      PMCID: PMC5937532          DOI: 10.1007/s00281-011-0292-6

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  169 in total

1.  The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype.

Authors:  Parviz Ahmad-Nejad; Salima Mrabet-Dahbi; Kristine Breuer; Martina Klotz; Thomas Werfel; Udo Herz; Klaus Heeg; Michael Neumaier; Harald Renz
Journal:  J Allergy Clin Immunol       Date:  2004-03       Impact factor: 10.793

Review 2.  Immune evasion by staphylococci.

Authors:  Timothy J Foster
Journal:  Nat Rev Microbiol       Date:  2005-12       Impact factor: 60.633

3.  Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Authors:  Eneida Villanueva; Srilakshmi Yalavarthi; Celine C Berthier; Jeffrey B Hodgin; Ritika Khandpur; Andrew M Lin; Cory J Rubin; Wenpu Zhao; Stephen H Olsen; Matthew Klinker; David Shealy; Michael F Denny; Joel Plumas; Laurence Chaperot; Matthias Kretzler; Allen T Bruce; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

Review 4.  Th17 cells in pathogenic simian immunodeficiency virus infection of macaques.

Authors:  Valentina Cecchinato; Genoveffa Franchini
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

Review 5.  Recognition of Staphylococcus aureus by the innate immune system.

Authors:  Bénédicte Fournier; Dana J Philpott
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus.

Authors:  L Mölne; M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

7.  Lucky number seven: RNase 7 can prevent Staphylococcus aureus skin colonization.

Authors:  John S Cho; Caiyun Xuan; Lloyd S Miller
Journal:  J Invest Dermatol       Date:  2010-12       Impact factor: 8.551

8.  Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis.

Authors:  Y X Zhao; A Tarkowski
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

9.  Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.

Authors:  Robin R Craven; Xi Gao; Irving C Allen; Denis Gris; Juliane Bubeck Wardenburg; Erin McElvania-Tekippe; Jenny P Ting; Joseph A Duncan
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

10.  Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.

Authors:  Cheng-Lung Ku; Horst von Bernuth; Capucine Picard; Shen-Ying Zhang; Huey-Hsuan Chang; Kun Yang; Maya Chrabieh; Andrew C Issekutz; Coleen K Cunningham; John Gallin; Steven M Holland; Chaim Roifman; Stephan Ehl; Joanne Smart; Mimi Tang; Franck J Barrat; Ofer Levy; Douglas McDonald; Noorbibi K Day-Good; Richard Miller; Hidetoshi Takada; Toshiro Hara; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; David Speert; Damien Sanlaville; Xiaoxia Li; Frédéric Geissmann; Eric Vivier; László Maródi; Ben-Zion Garty; Helen Chapel; Carlos Rodriguez-Gallego; Xavier Bossuyt; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  63 in total

1.  Interleukin-17A (IL-17A) and IL-17F Are Critical for Antimicrobial Peptide Production and Clearance of Staphylococcus aureus Nasal Colonization.

Authors:  Nathan K Archer; Nithin D Adappa; James N Palmer; Noam A Cohen; Jan M Harro; Steven K Lee; Lloyd S Miller; Mark E Shirtliff
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

2.  The good side of inflammation: Staphylococcus aureus proteins SpA and Sbi contribute to proper abscess formation and wound healing during skin and soft tissue infections.

Authors:  Cintia D Gonzalez; Camila Ledo; Eliana Cela; Inés Stella; Chunliang Xu; Diego S Ojeda; Paul S Frenette; Marisa I Gómez
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-07-09       Impact factor: 5.187

Review 3.  The influence of skin microorganisms on cutaneous immunity.

Authors:  Yasmine Belkaid; Samira Tamoutounour
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 4.  Pathogenesis of Staphylococcus aureus abscesses.

Authors:  Scott D Kobayashi; Natalia Malachowa; Frank R DeLeo
Journal:  Am J Pathol       Date:  2015-03-04       Impact factor: 4.307

5.  Immunomodulatory effects of recombinant lactoferrin during MRSA infection.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Int Immunopharmacol       Date:  2014-03-06       Impact factor: 4.932

Review 6.  Innate Antiviral Immunity in the Skin.

Authors:  Chelsea Handfield; Jeffery Kwock; Amanda S MacLeod
Journal:  Trends Immunol       Date:  2018-03-08       Impact factor: 16.687

7.  Daily very low UV dose exposure enhances adaptive immunity, compared with a single high-dose exposure. Consequences for the control of a skin infection.

Authors:  Eliana M Cela; Cintia Daniela Gonzalez; Adrian Friedrich; Camila Ledo; Mariela Laura Paz; Juliana Leoni; Marisa Inés Gómez; Daniel H González Maglio
Journal:  Immunology       Date:  2018-02-15       Impact factor: 7.397

8.  Association between vitamin D deficiency and methicillin-resistant Staphylococcus aureus infection.

Authors:  Jenna Thomason; Christopher Rentsch; Edward A Stenehjem; Alicia I Hidron; David Rimland
Journal:  Infection       Date:  2015-07-04       Impact factor: 3.553

Review 9.  Neutrophil migration in infection and wound repair: going forward in reverse.

Authors:  Sofia de Oliveira; Emily E Rosowski; Anna Huttenlocher
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

10.  Temporins A and B stimulate migration of HaCaT keratinocytes and kill intracellular Staphylococcus aureus.

Authors:  Antonio Di Grazia; Vincenzo Luca; Li-Av T Segev-Zarko; Yechiel Shai; Maria Luisa Mangoni
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.